ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,247Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 189

$1.05M Total Retail Price of All Prescriptions

Rank: 5 out of 189

752 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 752 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

19% of this provider’s 752 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 12,107 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 584 285 S3 1 1
LISINOPRIL 565 466 2 2
METFORMIN HCL 560 398 3 6
SIMVASTATIN 521 416 4 4
LEVOTHYROXINE SODIUM 496 377 5 3
IPRATROPIUM-ALBUTEROL 365 169 6 141
AMLODIPINE BESYLATE 358 271 7 5
FUROSEMIDE 354 253 8 7
ATORVASTATIN CALCIUM 336 286 9 14
METOPROLOL TARTRATE 336 265 9 11
POTASSIUM CHLORIDE 297 240 11 10
OMEPRAZOLE 265 199 12 8
GLYBURIDE 226 170 R 13 54
ZOLPIDEM TARTRATE 222 149 14 18
NEXIUM 212 140 15 9
WARFARIN SODIUM 211 122 16 24
LANTUS 207 146 17 40
PREDNISONE 193 145 18 45
GLIPIZIDE 192 161 19 43
IBUPROFEN 182 130 20 36
HYDROCHLOROTHIAZIDE 176 162 21 13
TAMSULOSIN HCL 175 171 22 26
CITALOPRAM HBR 157 67 23 25
CRESTOR 153 112 24 20
NOVOLIN R 145 91 25 145
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 121 26 19
TRAMADOL HCL 141 91 27 12
METFORMIN HCL ER 140 109 28 74
GABAPENTIN 140 82 28 15
SERTRALINE HCL 132 100 30 28
DONEPEZIL HCL 130 125 31 23
RANITIDINE HCL 124 91 32 42
HEPARIN SODIUM 124 84 32 217
ENALAPRIL MALEATE 115 72 34 53
CYMBALTA 114 77 35 46
AZITHROMYCIN 108 71 36 30
METOPROLOL SUCCINATE 108 79 36 16
LOSARTAN POTASSIUM 105 66 38 31
ACTOS 101 80 39 93
LEVETIRACETAM 100 46 40 112
PRAVASTATIN SODIUM 98 91 41 17
METOCLOPRAMIDE HCL 95 60 42 115
BENAZEPRIL HCL 89 73 43 71
BACLOFEN 88 33 44 121
DIOVAN HCT 88 80 44 44
SINGULAIR 87 43 46 94
PHENYTOIN 87 25 46 241
CYCLOBENZAPRINE HCL 85 47 R 48 66
LOVASTATIN 85 76 48 60
CARVEDILOL 85 85 48 22
DIOVAN 84 70 51 34
NIFEDIPINE ER 84 83 51 124
CEFEPIME HCL 83 33 10 53 247
LOSARTAN-HYDROCHLOROTHIAZIDE 83 80 53 59
MUPIROCIN 82 59 55 133
CLOPIDOGREL 82 68 55 29
PANTOPRAZOLE SODIUM 82 50 55 52
ALBUTEROL SULFATE 82 62 55 130
FLUTICASONE PROPIONATE 81 49 59 50
IPRATROPIUM BROMIDE 81 51 59 208
INSULIN SYRINGE 81 47 59 80
TRAZODONE HCL 80 40 62 41
NAMENDA 79 74 63 33
RAMIPRIL 78 53 64 75
ALENDRONATE SODIUM 78 70 64 27
KETOCONAZOLE 75 39 66 254
NAPROXEN 75 51 66 55
RISPERIDONE 75 43 66 51
QUETIAPINE FUMARATE 73 42 69 69
CIPROFLOXACIN HCL 67 52 70 39
LYRICA 65 46 71 67
TRIAMCINOLONE ACETONIDE 62 43 72 144
GLYCOPYRROLATE 62 16 72 269
PLAVIX 62 51 72 38
MONTELUKAST SODIUM 61 29 75 168
OXYBUTYNIN CHLORIDE 60 53 76 149
LIPITOR 58 44 77 92
TIZANIDINE HCL 58 27 77 118
LEVOFLOXACIN 56 25 79 96
DOXEPIN HCL 55 36 80 196
SANTYL 55 17 80 209
AMOXICILLIN 53 33 82 49
ESCITALOPRAM OXALATE 52 40 83 62
LOVAZA 51 48 84 125
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 41 85 65
GLIMEPIRIDE 50 38 85 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.